Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1

[1]  J. Reynolds,et al.  Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency , 2020, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[2]  Y. Ba,et al.  Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903) , 2020, BMC Cancer.

[3]  Y. Kajiyama,et al.  Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching , 2020, Esophagus.

[4]  H. Sugita,et al.  Association of the primary tumor’s SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study , 2019, International Journal of Clinical Oncology.

[5]  H. Sasano,et al.  GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy , 2019, BMC Cancer.

[6]  Y. Tachimori,et al.  Comprehensive Registry of Esophageal Cancer in Japan, 2011 , 2018, Esophagus.

[7]  K. Muro,et al.  Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A) , 2017, Japanese journal of clinical oncology.

[8]  M. Shinoda,et al.  Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer , 2016, Medicine.

[9]  E. Steyerberg,et al.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. , 2015, The Lancet. Oncology.

[10]  Z. Dai,et al.  Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus: A Phase III Randomized Trial , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  A. Viste,et al.  Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  T. Joh,et al.  Multicenter, prospective trial of white-light imaging alone versus white-light imaging followed by magnifying endoscopy with narrow-band imaging for the real-time imaging and diagnosis of invasion depth in superficial esophageal squamous cell carcinoma. , 2015, Gastrointestinal endoscopy.

[13]  T. Kawano,et al.  Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303) , 2015, Cancer science.

[14]  Y. Tachimori,et al.  Comprehensive Registry of Esophageal Cancer in Japan, 2008 , 2015, Esophagus.

[15]  K. Muro,et al.  Comparison between neoadjuvant chemotherapy followed by surgery (NAC-S) and definitive chemoradiotherapy (CRT) in overall survival for patients with clinical stage II-III esophageal squamous cell carcinoma (ESCC) (JCOG1406-A). , 2015 .

[16]  Y. Kitagawa,et al.  Comparison of Transthoracic Esophagectomy with Definitive Chemoradiotherapy as Initial Treatment for Patients with Esophageal Squamous Cell Carcinoma Who Could Tolerate Transthoracic Esophagectomy , 2015, Annals of Surgical Oncology.

[17]  J. Bosset,et al.  Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  X. Xie,et al.  Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies. , 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[19]  M. Azuma,et al.  Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2). , 2014, International journal of radiation oncology, biology, physics.

[20]  D. Ferry,et al.  Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial. , 2014, The Lancet. Oncology.

[21]  Meidong Xu,et al.  Risk factors for postoperative stricture after endoscopic submucosal dissection for superficial esophageal carcinoma , 2014, Endoscopy.

[22]  K. Muro,et al.  A phase II study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905-DI) , 2014, Esophagus.

[23]  L. Lundell,et al.  Meta‐analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro‐oesophageal junctional cancers , 2014, The British journal of surgery.

[24]  H. Daiko,et al.  Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study). , 2013, Japanese journal of clinical oncology.

[25]  N. Uedo,et al.  Intralesional steroid injection to prevent stricture after endoscopic submucosal dissection for esophageal cancer: a controlled prospective study , 2012, Endoscopy.

[26]  Charles R. Thomas,et al.  Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-II Study of The SWOG (S0414) , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  M. Yano,et al.  Influence of preoperative chemotherapy for advanced thoracic oesophageal squamous cell carcinoma on perioperative complications , 2011, The British journal of surgery.

[28]  M. Takeuchi,et al.  The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. , 2011, Gastrointestinal endoscopy.

[29]  K. Muro,et al.  Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). , 2011, International journal of radiation oncology, biology, physics.

[30]  K. Kaneko,et al.  Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia. , 2011, Japanese journal of clinical oncology.

[31]  V. Gebski,et al.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. , 2011, The Lancet. Oncology.

[32]  T. Nakayama,et al.  Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. , 2011, Gastrointestinal endoscopy.

[33]  Yasuo Hamamoto,et al.  A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy , 2011, Cancer Chemotherapy and Pharmacology.

[34]  J. Pignon,et al.  Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  T. Yano,et al.  Efficacy of Preventive Endoscopic Balloon Dilation for Esophageal Stricture After Endoscopic Resection , 2011, Journal of clinical gastroenterology.

[36]  J. Lv,et al.  Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. , 2010, World journal of gastroenterology.

[37]  R. Malthaner,et al.  WITHDRAWN. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. , 2010, The Cochrane database of systematic reviews.

[38]  K. Straif,et al.  A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. , 2009, The Lancet. Oncology.

[39]  A. Neugut,et al.  Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly , 2009, Cancer.

[40]  R. Goldbohm,et al.  Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study , 2009, Gut.

[41]  A. Sato,et al.  A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). , 2009, Japanese journal of clinical oncology.

[42]  F. Lordick,et al.  Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  S. Kato,et al.  Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. , 2009, International journal of radiation oncology, biology, physics.

[44]  N. Yamamichi,et al.  Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms , 2009, Endoscopy.

[45]  W. Ahrens,et al.  Diet and upper‐aerodigestive tract cancer in Europe: The ARCAGE study , 2009, International journal of cancer.

[46]  M. Inoue,et al.  Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). , 2009, Cancer letters.

[47]  M. Stuschke,et al.  Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  K. Ohtomo,et al.  A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[49]  L. Murray,et al.  The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. , 2008, American journal of epidemiology.

[50]  Yih-Leong Chang,et al.  Improved local control by surgery and paclitaxel‐based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non‐randomized study , 2008, Journal of surgical oncology.

[51]  S. Tanabe,et al.  A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501). , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[52]  D. Sugarbaker,et al.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  J. Fraumeni,et al.  A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. , 2008, European journal of cancer.

[54]  C. Abnet,et al.  Fruit and vegetable intake and esophageal cancer in a large prospective cohort study , 2007, International journal of cancer.

[55]  H. Honda,et al.  Treatment Outcomes of Radiotherapy for Patients With Stage I Esophageal Cancer: A Single Institute Experience , 2007, American journal of clinical oncology.

[56]  A. Livingstone,et al.  Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer. , 2007, Japanese journal of clinical oncology.

[57]  T. Conroy,et al.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  T. Crosby,et al.  A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[59]  F. Pasini,et al.  Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion , 2007, Journal of surgical oncology.

[60]  A. Ruol,et al.  Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer , 2007, British Journal of Cancer.

[61]  H. Okumura,et al.  Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[62]  Hiroshi Yamamoto,et al.  Neoadjuvant chemoradiotherapy followed by esophagectomy versus definitive chemoradiotherapy in resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma , 2006, Esophagus.

[63]  Y. Tamaki,et al.  Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: Indications for surgery or combined chemoradiotherapy , 2006, Journal of gastroenterology and hepatology.

[64]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[65]  D. Corley,et al.  Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[66]  T. Tamamoto,et al.  Prospective trial of radiotherapy for patients 80 years of age or older with squamous cell carcinoma of the thoracic esophagus. , 2006, International journal of radiation oncology, biology, physics.

[67]  T. Nakajima,et al.  Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[68]  Takayuki Matsumoto,et al.  Probe EUS for the diagnosis of invasion depth in superficial esophageal cancer: a comparison between a jelly-filled method and a water-filled balloon method. , 2006, Gastrointestinal endoscopy.

[69]  V. Gebski,et al.  Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. , 2005, The Lancet. Oncology.

[70]  L. Lundell,et al.  Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. , 2005, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[71]  S. Leung,et al.  Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: Early results from the Chinese University Research Group for Esophageal Cancer (CURE) , 2005, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.

[72]  T. Hashimoto,et al.  Smoking, Alcohol Drinking and Esophageal Cancer: Findings from the JACC Study , 2005, Journal of epidemiology.

[73]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  H. Honda,et al.  Clinical Results of Radiation Therapy for Stage I Esophageal Cancer: A Single Institutional Experience , 2005, American journal of clinical oncology.

[75]  E. Kuipers,et al.  Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial , 2004, The Lancet.

[76]  M. Shinoda,et al.  Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). , 2004, Japanese journal of clinical oncology.

[77]  T. Nakajima,et al.  Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma , 2004 .

[78]  I. Hyodo,et al.  A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[79]  J. Lee,et al.  A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[80]  H. Yamana,et al.  Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  S. Nag,et al.  Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. , 2003, Brachytherapy.

[82]  S. Yoshida,et al.  Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. , 2003, International journal of radiation oncology, biology, physics.

[83]  L. Zuraw,et al.  Clinical investigation: esophagusCombined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: A practice guideline☆ , 2003 .

[84]  S. Yoshida,et al.  Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. , 2003, Gastrointestinal endoscopy.

[85]  G. Noël,et al.  INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy , 2002 .

[86]  T. Kawano,et al.  Magnifying Endoscopy, Stereoscopic Microscopy, and the Microvascular Architecture of Superficial Esophageal Carcinoma , 2002, Endoscopy.

[87]  R. Ginsberg,et al.  INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  S. Nag,et al.  Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. , 2001, International journal of radiation oncology, biology, physics.

[89]  S. Morrill,et al.  Bi-modality (chemo-radiation) versus tri-modality (chemo-radiation followed by surgery) treatment for carcinoma of the esophagus. , 2001, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[90]  T. Iwaya,et al.  Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. , 2001, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[91]  H. Yamana,et al.  Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407). , 2001, Japanese journal of clinical oncology.

[92]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[93]  S. Yoshida,et al.  Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  J. Cooper,et al.  Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01) , 1999 .

[95]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[96]  C. Falkson,et al.  A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. , 1998, American journal of clinical oncology.

[97]  S. Tsugane,et al.  A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. , 1997, The Journal of thoracic and cardiovascular surgery.

[98]  J. Bosset,et al.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. , 1997, The New England journal of medicine.

[99]  L. Collette,et al.  Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. , 1997, European journal of cancer.

[100]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[101]  A. Fingerhut,et al.  5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research. , 1996, Annals of surgery.

[102]  P. Puttisak,et al.  A prospective study of combined therapy in esophageal cancer. , 1994, Hepato-gastroenterology.

[103]  M. Hassel,et al.  A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus , 1994, Cancer.

[104]  R. Hatlevoll,et al.  Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer , 1992, World Journal of Surgery.

[105]  H. Watanabe,et al.  Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. , 1992, Japanese journal of clinical oncology.

[106]  M. Shinoda,et al.  A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) , 2011, Annals of Surgical Oncology.

[107]  Y. Tachimori,et al.  Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. , 2009, The Journal of thoracic and cardiovascular surgery.

[108]  S. Asbell,et al.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.